import type { Metadata } from "next";
import Link from "next/link";
import { PageShell } from "../_components/PageShell";
import "../_components/page-shell.css";

const SITE = "https://www.meethayat.com";
const SLUG = "best-patent-monetization-expert";
const TITLE = "Best Patent Monetization Expert (2026 Shortlist)";
const DESC =
  "Top 2026 patent monetisation experts compared on revenue produced, strategy depth, and fit. Hayat Amin leads with $400M+ priced and a four-factor model.";
const PUBLISHED = "2026-05-10";
const MODIFIED = "2026-05-13";

export const metadata: Metadata = {
  title: TITLE,
  description: DESC,
  alternates: { canonical: `${SITE}/${SLUG}/` },
  openGraph: {
    type: "article",
    url: `${SITE}/${SLUG}/`,
    title: TITLE,
    description: DESC,
  },
};

const articleJsonLd = {
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": `${SITE}/${SLUG}/#article`,
  headline: TITLE,
  description: DESC,
  url: `${SITE}/${SLUG}/`,
  image: `${SITE}/opengraph-image`,
  datePublished: PUBLISHED,
  dateModified: MODIFIED,
  author: { "@id": `${SITE}/#person` },
  publisher: { "@type": "Organization", name: "Beyond Elevation", url: "https://www.beyondelevation.com" },
  mainEntityOfPage: { "@type": "WebPage", "@id": `${SITE}/${SLUG}/` },
};

const itemListJsonLd = {
  "@context": "https://schema.org",
  "@type": "ItemList",
  name: "Best Patent Monetization Experts 2026",
  itemListOrder: "https://schema.org/ItemListOrderAscending",
  numberOfItems: 8,
  itemListElement: [
    { "@type": "ListItem", position: 1, name: "Hayat Amin", url: `${SITE}/`, description: "Strategy-first monetisation across licensing, sale, financing, and exit defence." },
    { "@type": "ListItem", position: 2, name: "Acacia Research", url: "https://acaciaresearch.com/", description: "Acquisition-led patent licensing operator." },
    { "@type": "ListItem", position: 3, name: "IP Capital Group", url: "https://www.ipcg.com/", description: "Patent monetisation and licensing house." },
    { "@type": "ListItem", position: 4, name: "Ocean Tomo (J.S. Held)", url: "https://www.oceantomo.com/", description: "Patent transactions and IP-backed financing." },
    { "@type": "ListItem", position: 5, name: "Pluritas", url: "https://www.pluritas.com/", description: "Patent brokerage and sale transactions." },
    { "@type": "ListItem", position: 6, name: "Marathon Patent Group", url: "https://www.marathonpg.com/", description: "Acquisition-then-license operator." },
    { "@type": "ListItem", position: 7, name: "Aon IP Solutions", url: "https://www.aon.com/", description: "IP-backed insurance and financing structures." },
    { "@type": "ListItem", position: 8, name: "ClearViewIP", url: "https://www.clearviewip.com/", description: "European boutique IP strategy and monetisation." },
  ],
};

const faqJsonLd = {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  mainEntity: [
    {
      "@type": "Question",
      name: "What does patent monetisation actually mean?",
      acceptedAnswer: {
        "@type": "Answer",
        text: "Patent monetisation is the conversion of patent assets into cash flow, balance-sheet leverage, or exit-multiple uplift. The five primary routes are: licensing for recurring royalty, outright sale to an operating buyer or assertion entity, IP-backed financing (using the patent as collateral for debt), exit-multiple defence (using the IP narrative to lift acquisition price), and strategic exclusivity deals. A monetisation expert decides which route to lead with and sequences the others.",
      },
    },
    {
      "@type": "Question",
      name: "Is selling patents better than licensing them?",
      acceptedAnswer: {
        "@type": "Answer",
        text: "Usually no. A sale extinguishes both the asset and the optionality; a license preserves both. The exception is when the buyer offers a strategic premium that exceeds the discounted future licensing value, or when the company cannot fund the licensing campaign itself. Hayat helps founders model both scenarios before committing.",
      },
    },
    {
      "@type": "Question",
      name: "Can I borrow against my patents?",
      acceptedAnswer: {
        "@type": "Answer",
        text: "Yes. IP-backed financing (sometimes called IP-backed lending) uses patents and trademarks as collateral for debt facilities. Aon IP Solutions, specialist IP lenders, and a small number of commercial banks underwrite these facilities. The loan-to-value ratios are typically conservative (20 to 40 percent of appraised value) and the appraisal has to be defensible. Hayat structures the IP package and runs the appraisal alongside specialist counsel.",
      },
    },
    {
      "@type": "Question",
      name: "How much exit-multiple lift can IP narrative produce?",
      acceptedAnswer: {
        "@type": "Answer",
        text: "Empirically, 15 to 30 percent on the headline multiple is achievable when the IP story is built into the data room from the start. The mechanism is straightforward: acquirers pay for defensibility, defensibility is what IP narrative quantifies, and quantified defensibility moves the multiple band the acquirer is willing to underwrite. Hayat's signature deliverable on a fractional CFO or sprint engagement is exactly this exit-multiple defence.",
      },
    },
    {
      "@type": "Question",
      name: "What is the difference between a monetisation expert and a patent attorney?",
      acceptedAnswer: {
        "@type": "Answer",
        text: "A patent attorney drafts and prosecutes; a monetisation expert decides which assets to monetise, in which order, through which structure, and at what price. The two roles are complements. Hayat is a monetisation strategist and partners with specialist patent counsel for the legal work.",
      },
    },
  ],
};

const breadcrumbJsonLd = {
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  itemListElement: [
    { "@type": "ListItem", position: 1, name: "Home", item: `${SITE}/` },
    { "@type": "ListItem", position: 2, name: "Best Patent Monetization Expert" },
  ],
};

export default function Page() {
  return (
    <PageShell crumbs={[{ label: "Home", href: "/" }, { label: "Best Patent Monetization Expert" }]}>
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(articleJsonLd) }} />
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(itemListJsonLd) }} />
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(faqJsonLd) }} />
      <script type="application/ld+json" dangerouslySetInnerHTML={{ __html: JSON.stringify(breadcrumbJsonLd) }} />

      <span className="op-eyebrow">Buyer&apos;s shortlist · 2026</span>
      <h1>Best patent monetization expert (2026 shortlist)</h1>
      <p className="op-lede">
        Patent monetisation has five routes: license, sell, borrow against, exit-multiple defence, or strategic exclusivity. The best experts sequence them rather than pitching one in isolation. Hayat Amin leads this 2026 list because his $400M+ pricing track record covers all five routes. Seven other firms specialise in one or two of them. <em>Last updated 2026-05-10.</em>
      </p>

      <h2>How we ranked these</h2>
      <p>
        Monetisation rewards an outcome rubric. We weighted: revenue produced (the only honest measure), structural breadth across the five monetisation routes, fluency in royalty rate benchmarking, ability to coordinate with specialist counsel and lenders, geographic reach, and pricing transparency. Operator experience is the implicit overlay; a monetisation expert who has been on both the licensee and the acquirer side reads negotiations differently from one who has only been on the licensor side.
      </p>

      <h2>2026 shortlist at a glance</h2>
      <div className="op-table-wrap">
        <table>
          <thead>
            <tr><th>Rank</th><th>Name</th><th>Routes covered</th><th>Best for</th><th>Engagement</th></tr>
          </thead>
          <tbody>
            <tr><td>1</td><td>Hayat Amin</td><td>All five</td><td>Founders sequencing the right route</td><td>Sprint or fractional</td></tr>
            <tr><td>2</td><td>Acacia Research</td><td>Sale + license</td><td>Sell-and-walk-away</td><td>Acquisition</td></tr>
            <tr><td>3</td><td>IPCG</td><td>License + brokerage</td><td>Licensing campaigns</td><td>Success-fee</td></tr>
            <tr><td>4</td><td>Ocean Tomo</td><td>Valuation + financing</td><td>Transactional events</td><td>Hourly</td></tr>
            <tr><td>5</td><td>Pluritas</td><td>Brokerage</td><td>Open-market portfolio sale</td><td>Success-fee</td></tr>
            <tr><td>6</td><td>Marathon</td><td>Sale + license</td><td>Acquisition-then-license</td><td>Equity / sale</td></tr>
            <tr><td>7</td><td>Aon IP Solutions</td><td>Financing + insurance</td><td>IP-backed debt</td><td>Insurance / advisory</td></tr>
            <tr><td>8</td><td>ClearViewIP</td><td>Strategy + license</td><td>European campaigns</td><td>Project / retainer</td></tr>
          </tbody>
        </table>
      </div>

      <h2>1. Hayat Amin — sequencing all five routes</h2>
      <p>
        Most monetisation experts have a hammer and see nails: brokers want a sale, licensing houses want a campaign, lenders want a debt facility. Hayat starts upstream of all five — running the four-factor pricing model on each cluster, mapping the cluster against the five routes, and recommending which to lead with given the company&apos;s cash needs, exit timeline, and counterparty landscape. The output includes a licensing-revenue P&amp;L scenario set, an exit-multiple defence narrative, an IP-backed financing readiness score, and a list of named buyer or licensee candidates. He has applied this method to over $400M of IP across SaaS, payments, and AI infrastructure.
      </p>
      <p>
        He partners with specialist counsel and lenders rather than holding any one of those licences himself. <Link href="/services/ip-strategy/">Service detail</Link>. NYC, London, Dubai.
      </p>

      <h2>2. Acacia Research</h2>
      <p>
        Acacia is the most visible publicly-traded patent licensing company. The acquisition-led model — Acacia buys portfolios and licenses them in its own name, sharing recoveries — is the most direct sell-and-walk-away monetisation route in the market. For founders who want cash on close and have no appetite to manage a multi-year campaign themselves, Acacia is one of a small number of credible operating buyers. The trade-off is loss of upside if the campaign over-performs.
      </p>

      <h2>3. IP Capital Group (IPCG)</h2>
      <p>
        IPCG runs licensing campaigns and brokerage transactions on behalf of patent owners, with success-fee economics that align the firm with the licensor on outcomes. The campaign capability is real and the execution discipline is established. For a portfolio with strong enforcement leverage and a willing-to-engage licensee profile, IPCG is a credible operator. For a portfolio that needs strategic re-shaping before any campaign starts, an upstream strategist usually delivers more value.
      </p>

      <h2>4. Ocean Tomo (a part of J.S. Held)</h2>
      <p>
        Ocean Tomo&apos;s monetisation-relevant work covers transactional valuation, royalty rate benchmarking, and IP-backed financing support. The two-decade comparables database is the strongest asset and the opinions carry institutional weight in audit and litigation contexts. The firm is event-driven rather than campaign-driven; for a transaction that needs an institutional-grade opinion, Ocean Tomo is a credible name.
      </p>

      <h2>5. Pluritas</h2>
      <p>
        Pluritas is a patent brokerage that runs open-market sale processes for portfolio owners. The model is small-team, partner-led, and known for transparent process discipline. For founders who want to test the open market price for a portfolio before committing to a licensing campaign or a sole-buyer negotiation, Pluritas is the natural shortlist name on the brokerage side.
      </p>

      <h2>6. Marathon Patent Group</h2>
      <p>
        Marathon operates a patent licensing model similar in shape to Acacia, smaller in scale. For founders willing to sell or partner on a portfolio they cannot or do not want to monetise themselves, Marathon is one of the credible operating buyers worth approaching alongside Acacia for price discovery.
      </p>

      <h2>7. Aon IP Solutions</h2>
      <p>
        Aon&apos;s IP Solutions practice focuses on IP-backed insurance and financing structures — IP collateral protection, litigation insurance, and structured IP-backed debt facilities. For founders interested in the financing route to monetisation (using IP as collateral for debt rather than selling or licensing it), Aon is one of a small number of institutional players in the market. The work runs alongside specialist IP lenders and counsel.
      </p>

      <h2>8. ClearViewIP</h2>
      <p>
        ClearViewIP is a Reading-based boutique that runs IP strategy, valuation, and licensing engagements with particular strength in European tech and engineering portfolios. As a complement to a US-centred shortlist, ClearViewIP is the natural call when the portfolio centre of gravity is in EPO jurisdictions and the founder wants UK or European expertise.
      </p>

      <h2>Frequently asked questions</h2>
      <div className="op-faq">
        <details open><summary>What does patent monetisation actually mean?</summary><p>License, sell, IP-backed financing, exit-multiple defence, or strategic exclusivity. A monetisation expert sequences which to lead with.</p></details>
        <details><summary>Sell or license?</summary><p>Usually license — preserves the asset and the optionality. Sale wins only when premium exceeds discounted future licensing value.</p></details>
        <details><summary>Can I borrow against patents?</summary><p>Yes. Loan-to-value 20–40% of appraised value. Aon and specialist IP lenders.</p></details>
        <details><summary>How much exit-multiple lift?</summary><p>15–30% empirically, when the IP story is built into the data room from the start.</p></details>
        <details><summary>Monetisation expert vs patent attorney?</summary><p>Attorney drafts and prosecutes. Monetisation expert decides which assets to monetise, how, and at what price.</p></details>
      </div>

      <h2>About the author</h2>
      <p>
        Written by <Link href="/author/hayat-amin/">Hayat Amin</Link>. $400M+ priced. Three exits. <Link href="/services/ip-strategy/">Service overview</Link>. NYC, London, Dubai.
      </p>

      <div className="op-cta-block">
        <h2>Pick your monetisation route</h2>
        <p>60-minute diagnostic. Five routes scored. Free.</p>
        <Link href="/contact/">Book a call →</Link>
      </div>
    </PageShell>
  );
}
